SCHEMBL9017599

SCHEMBL9017599

OC(=S)c1ccccc1O.[BiH3]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 9/20 0.54
ALDH1A1 P00352 7/20 0.54
KDM4E B2RXH2 6/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
CA1 P00915 3/20 0.54
CA9 Q16790 3/20 0.54
CA12 O43570 2/20 0.54
CA2 P00918 2/20 0.54
CA4 P22748 2/20 0.54
CA14 Q9ULX7 2/20 0.54
HMGB1 P09429 1/20 0.54
CA6 P23280 1/20 0.54
CA7 P43166 1/20 0.54
NAPRT Q6XQN6 1/20 0.54
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
HSD17B10 Q99714 7/20 0.47
MAPT P10636 5/20 0.47
ALOX15 P16050 4/20 0.47
POLB P06746 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30043535 0.97 HPGD (0.56) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL61048 0.97 HPGD (0.56) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL11209269 0.95 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL11206696 0.95 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL3626932 0.95 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL11210054 0.95 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL10726307 0.95 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL11208501 0.95 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL9335124 0.95 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL430368 0.95 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-8119862-A None JP disclosed
EP-3541368-B1 IMAGEABLE PARTICLES, METHODS OF MAKING AND METHODS OF USE THEREOF US HEALTH (US) 2023-07-12 EP disclosed
US-11382990-B2 Imageable polymers, methods of making and methods of use thereof THE USA, AS REPRESENTED BY THE SECRETARY, DHHS (US) 2022-07-12 US disclosed
US-20200197540-A1 Imageable Polymers, Methods of Making and Methods of Use Thereof THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2020-06-25 US disclosed
EP-3541368-A1 IMAGEABLE PARTICLES, METHODS OF MAKING AND METHODS OF USE THEREOF The United States of America, as represented by the Secretary, Department of Health and Human Services (US) 2019-09-25 EP disclosed
WO-2018093566-A1 IMAGEABLE PARTICLES, METHODS OF MAKING AND METHODS OF USE THEREOF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2018-05-24 WO disclosed
JP-H08119862-A BISMUTH COMPLEX AND ANTIBACTERIAL AGENT CONTAINING THE SAME YASUSATO EIJI 1996-05-14 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11382990-B2 Imageable polymers, methods of making and methods of use thereof PUF60, PBRM1, PCBP1 HPGD 1801/4885ALDH1A1 4268/4885KDM4E 1954/4885
US-20200197540-A1 Imageable Polymers, Methods of Making and Methods of Use Thereof PUF60, PBRM1, PCBP1 HPGD 1801/4885ALDH1A1 4268/4885KDM4E 1954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.